View up-to-date information on Arvinas Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2022221386A1 | Application | Cereblon ligands and bifunctional compounds comprising the same | A61K31/454; A61K31/4725; A61P35/00; A61P35/02; C07D401/04; C07D401/14; C07D417/14; C07D471/04; C07D471/10; C07D487/04; C07D495/14; C07D498/04 | September 15, 2022 |
| AU2022221407A1 | Application | Modulators of estrogen receptor proteolysis and associated methods of use | A61K31/381; A61P35/00; C07D401/14; C07D403/06; C07D403/14; C07D405/14; C07D409/12; C07D409/14; C07D413/14; C07D417/12; C07D417/14; C07D471/04 | September 15, 2022 |
| US20220274955A1 | Application | TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | A61K31/454; A61K31/4545; A61K31/4725; A61K31/496; A61K31/497; A61K31/501; A61K31/519; A61K31/5386; A61K31/551; A61K38/05; A61K38/06; A61K45/06; A61K47/54; A61K47/545; A61P15/00; A61P35/00; C07D401/04; C07D401/14; C07D471/04; C07D471/10; C07D487/04; C07D487/08; C07D487/10; C07D498/10; C07K5/06034; C07K5/06165; C07K5/0806 | September 01, 2022 |
| EP4048236A1 | Application | VERFAHREN ZUR BEHANDLUNG VON PROSTATAKREBS | A61K31/02; A61K31/166; A61K31/277; A61K31/497; A61K31/501; A61K31/506; A61K45/06; A61K9/0053; A61P35/00; C07D401/14 | August 31, 2022 |
| US11427548B2 | Grant | Compounds and methods for the targeted degradation of androgen receptor | A61K31/277; A61K31/4166; A61K31/4184; A61K31/4188; A61K31/435; A61K31/4439; A61K31/454; A61K45/06; A61K47/545; C07C255/54; C07C2601/04; C07C271/24; C07D213/82; C07D231/14; C07D233/86; C07D235/02; C07D237/24; C07D239/42; C07D241/28; C07D401/04; C07D401/08; C07D413/12; C07D413/14; C07D417/12; C07D417/14; C07D471/10; C07D491/107 | August 30, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer